Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.
Insamo's investors include Playground Global, Civilization Ventures, MRL Ventures Fund, venBio Partners, BEVC.
Insamo is headquartered in Berkeley, United States.
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.
Insamo is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Insamo — Funding & Investors." VCBacked, April 2, 2024, https://www.vcbacked.co/company/insamo. Accessed October 5, 2026.
VCBacked. (2024). Insamo — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/insamo
{{cite web |title=Insamo — Funding & Investors |url=https://www.vcbacked.co/company/insamo |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated